By Josh White
Date: Monday 11 Aug 2025
(Sharecast News) - Genedrive said in an update on Monday that its full-year income for the 12 months ended June doubled to around £1m, from £0.5m a year earlier, driven by stronger second-half sales.
By Josh White
Date: Friday 30 May 2025
(Sharecast News) - Genedrive announced on Friday that it has secured CE certification for its CYP2C19 ID Kit under the European In Vitro Diagnostic Regulation (IVDR), allowing the pharmacogenetic test to be marketed and used across the EU and in certain non-European countries that recognise CE-IVD marking.
By Josh White
Date: Friday 27 Dec 2024
(Sharecast News) - Point-of-care pharmacogenetic testing specialist Genedrive announced on Friday that clinical performance data for its Genedrive CYP2C19-ID Kit had been published in the Journal of Molecular Biology.
Currency | UK Pounds |
Share Price | 0.78p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 2.93p |
52 Week Low | 0.74p |
Volume | 974,560 |
Shares Issued | 624.90m |
Market Cap | £4.84m |
RiskGrade | 747 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:22 | 18,767 @ 0.79p |
12:57 | 675,058 @ 0.77p |
11:29 | 24,717 @ 0.79p |
11:16 | 100,000 @ 0.77p |
11:10 | 30,018 @ 0.79p |
You are here: research